Purchase Order 75F40124P00331
Award Date
8/1/24
Potential Completion Date
7/31/25
Potential Value
$76K
Federal Agency
Food and Drug Administration
Awardee
Nova Biomedical Corp
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02454, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency, to Nova Biomedical Corp, a large, privately-owned manufacturer of advanced medical equipment and in-vitro diagnostic devices. The $135,445.00 firm fixed-price purchase order is for the delivery of a "NUTRIENT ANALYZER" with a completion date of January 21, 2024. The contract does not have a set-aside designation. Nova Biomedical Corp is a key supplier of critical care equipment and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $236,975.76 firm-fixed-price purchase order to Nova Biomedical Corp, a manufacturer of in-vitro diagnostic equipment, to procure Nova Bioprofile Flex 2 operational parts and components. This contract has a completion date of January 31, 2024 and was awarded on July 14, 2020 under a full and open competition. The original solicitation was a combined synopsis/solicitation for commercial items under FAR...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to Nova Biomedical Corp, a leading manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices. The contract, valued at $109,113.00, is for a maintenance agreement with an ultimate completion date of August 31, 2023. Nova Biomedical Corp, a large, privately-owned company, has a significant history of providing a wide range of medical...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to Nova Biomedical Corp, a manufacturer of advanced critical care blood gas analyzers and other in-vitro diagnostic equipment. The contract is for the procurement of one Nova BioProfile Flex 2 nutrient analyzer and accessories for an existing PacBio Sequel instrument at an FDA facility in Silver Spring, Maryland. The total potential value of the contract is $119,699.00. The original...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price purchase order contract to Nova Biomedical Corp, a manufacturer of advanced medical diagnostic equipment and supplies. The $73,777.00 contract is for the delivery of Nova BioProfile FLEX 1 and Nova BioProfile 2 devices. This award is not set aside. Nova Biomedical Corp has an extensive history of providing a wide range of medical equipment, reagents, and consumables to various federal...
Nova Biomedical Corp was awarded a firm fixed price purchase order totaling $186,632 by the Department of Health and Human Services Food and Drug Administration to deliver a nutrient analyzer as requested in Solicitation Number HHS-FDA-20-SOL-12345 issued on June 16, 2020. The purchase order does not include any set aside provisions. Performance will occur at the agency's Silver Spring, Maryland location through the period of September 23, 2025. Nova Biomedical is a manufacturer and...
This is a $23,700.00 firm fixed price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Nova Biomedical Corporation, a leading manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices. The contract is for the delivery of unspecified medical supplies, with a period of performance through May 22, 2024. No set-aside designation was used. Nova Biomedical has an extensive history of federal contract awards, including providing...
This is a federal contract award from the U.S. Food and Drug Administration (FDA) to Nova Biomedical Corporation, a leading manufacturer of advanced medical equipment and diagnostic devices. The contract, with a ceiling value of $160,625.00, was awarded on August 1, 2016 and has an ultimate completion date of July 31, 2021. The contract is a delivery order under the General Services Administration (GSA) Scientific Equipment and Services schedule (FSS-66) and is a firm fixed-price contract. The...
The U.S. government awarded a $23,700.00 firm fixed-price purchase order contract to Nova Biomedical Corp, a leading manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices. The contract, which does not have a set-aside designation, is to provide medical supplies to the Bureau of Administration, a civilian federal agency. The award has an ultimate completion date of June 15, 2024. Nova Biomedical Corp is a large, privately-owned company headquartered in...
The U.S. government awarded a $20,950.00 firm fixed-price purchase order contract to Nova Biomedical Corp, a large, privately-owned manufacturer of advanced medical equipment and diagnostic devices. The contract, issued by the Bureau of Administration, a civilian agency, is for the delivery of unspecified medical supplies to a location in Waltham, Massachusetts by November 20, 2024. Nova Biomedical has an extensive history of federal contract awards, including supplying blood gas analyzers,...